MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,288 | -95.2% | 2,491 | -97.4% | 0.00% | – |
| Q1 2023 | $67,983 | -29.5% | 96,157 | -25.2% | 0.00% | – |
| Q4 2022 | $96,406 | -33.1% | 128,541 | -23.3% | 0.00% | – |
| Q3 2022 | $144,000 | +220.0% | 167,505 | +318.8% | 0.00% | – |
| Q2 2022 | $45,000 | +21.6% | 40,000 | +71.6% | 0.00% | – |
| Q4 2021 | $37,000 | +54.2% | 23,306 | +134.3% | 0.00% | – |
| Q3 2021 | $24,000 | +700.0% | 9,949 | +969.8% | 0.00% | – |
| Q2 2021 | $3,000 | -82.4% | 930 | -81.8% | 0.00% | – |
| Q1 2021 | $17,000 | 0.0% | 5,119 | +10.3% | 0.00% | – |
| Q4 2020 | $17,000 | – | 4,639 | +2435.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 183 | -81.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 965 | -47.0% | 0.00% | – |
| Q1 2020 | $2,000 | -91.3% | 1,820 | -73.9% | 0.00% | – |
| Q4 2019 | $23,000 | +666.7% | 6,969 | +520.0% | 0.00% | – |
| Q3 2019 | $3,000 | +200.0% | 1,124 | +66.3% | 0.00% | – |
| Q2 2019 | $1,000 | – | 676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |